Efficacy and safety of once-weekly basal insulin analogs versus daily basal insulin analogs in adults with type 2 diabetes: a systematic review and meta-analysis
Dimitrios Raptis, Sotirios Chiotis, Theodoros Papamichalis, Eleni Bekiari, Apostolos Tsapas, Thomas Karagiannis · 2026
Read Efficacy and safety of once-weekly basal insulin analogs versus daily basal insulin analogs in adults with type 2 diabetes: a systematic review and meta-analysis by Dimitrios Raptis, Sotirios Chiotis, Theodoros Papamichalis, Eleni Bekiari, Apostolos Tsapas, Thomas Karagiannis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13260229.txt.
Description
Dimitrios Raptis and co-authors present a 2026 systematic review and meta-analysis of once-weekly versus daily basal insulin in adults with type 2 diabetes. Basal insulin is the long-acting background insulin used to control blood sugar between meals. New weekly versions, including insulin icodec and efsitora, aim to improve adherence and convenience. The review pooled fourteen randomized controlled trials with 8,487 subjects comparing the two schedules.
Weekly insulin lowered HbA1c, a measure of average blood sugar, slightly more than daily insulin, by a mean difference of 0.09 percent. Time spent in the target glucose range improved by 1.86 percent, and the odds of reaching an HbA1c below 7.0 percent were higher, with an odds ratio of 1.32. Rates of serious low blood sugar episodes did not differ significantly. The main gain is fewer injections, the authors say.
Catalog record
| CREATOR | Dimitrios Raptis, Sotirios Chiotis, Theodoros Papamichalis, Eleni Bekiari, Apostolos Tsapas, Thomas Karagiannis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43086 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |